Update on the use of immunoglobulin in human disease: a review of evidence

EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

[HTML][HTML] Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review

J Alijotas-Reig, E Esteve-Valverde… - Journal of clinical …, 2022 - mdpi.com
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …

Uterine natural killer cells: from foe to friend in reproduction

I Díaz-Hernández, D Alecsandru… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Recurrent miscarriage and pre-eclampsia are common reproductive
disorders, but their causes are often unknown. Recent evidence has provided new insight …

Assessment and treatment of repeated implantation failure (RIF)

A Simon, N Laufer - Journal of assisted reproduction and genetics, 2012 - Springer
Repeated implantation failure (RIF) is determined when embryos of good quality fail to
implant following several in vitro fertilization (IVF) treatment cycles. Implantation failure is …

Exposure to bisphenol A is associated with recurrent miscarriage

M Sugiura-Ogasawara, Y Ozaki, S Sonta… - Human …, 2005 - academic.oup.com
BACKGROUND: Little is known about the influence of high exposure to bisphenol A on
recurrent miscarriage and immunoendocrine abnormalities. METHODS: Serum bisphenol A …

[HTML][HTML] Recurrent implantation failure: the role of the endometrium

T Timeva, A Shterev, S Kyurkchiev - Journal of reproduction & …, 2014 - ncbi.nlm.nih.gov
The success rate of reproductive treatment methods depends on many different factors. The
most important and discussed ones in the literature are maternal age, the causes of …

Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives

C Dosiou, LC Giudice - Endocrine reviews, 2005 - academic.oup.com
The endocrine system and the immune system interact closely during implantation and
maintenance of pregnancy. One of the most striking examples of this communication is at the …

Immunotherapy for recurrent miscarriage

LF Wong, TF Porter, JR Scott - Cochrane Database of …, 2014 - cochranelibrary.com
Background Because immunological aberrations might be the cause of miscarriage in some
women, several immunotherapies have been used to treat women with otherwise …

[HTML][HTML] Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art

K Vomstein, K Feil, L Strobel, A Aulitzky… - Journal of clinical …, 2021 - mdpi.com
Around 1–5% of all couples experience recurrent pregnancy loss (RPL). Established risk
factors include anatomical, genetic, endocrine, and hemostatic alterations. With around 50 …

Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells

J Alijotas-Reig, E Llurba, JM Gris - Placenta, 2014 - Elsevier
The maternal immune system needs to adapt to tolerate the semi-allogeneic conceptus.
Since maternal allo-reactive lymphocytes are not fully depleted, other local/systemic …